Colorectal Cancer Drugs are drugs for the treatment of colorectal cancer.
Based on the Colorectal Cancer Drugs market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Colorectal Cancer Drugs market covered in Chapter 5:
Otsuka Pharmaceutical
Mylan
Merck Serono
Precision Biologics
Biothera
Eli Lilly
Nektar Therapeutics
Symphogen
ThromboGenics
Taiho
Yakult Honsha
F. Hoffmann-La Roche
Eisai
Amgen
Advenchen Laboratories
Daiichi Sankyo
Bristol-Myers Squibb
Debiopharm
Takeda
Aeterna Zentaris
Oncothyreon
Bavarian Nordic
Xbiotech
Teva
Accord Healthcare
Mologen
Immodulon Therapeutics
Sun Pharmaceutical
Boehringer Ingelheim
AstraZeneca
Bayer
In Chapter 6, on the basis of types, the Colorectal Cancer Drugs market from 2015 to 2025 is primarily split into:
Adenocarcinoma
Gastrointestinal Stromal Tumors (GIST)
Lymphoma
Carcinoids
Turcot Syndrome
Peutz-Jeghers Syndrome (PJS)
Familial Colorectal Cancer (FCC)
Juvenile Polyposis Coli
In Chapter 7, on the basis of applications, the Colorectal Cancer Drugs market from 2015 to 2025 covers:
Targeted Drug
Non-Targeted Drug
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Colorectal Cancer Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Otsuka Pharmaceutical
5.1.1 Otsuka Pharmaceutical Company Profile
5.1.2 Otsuka Pharmaceutical Business Overview
5.1.3 Otsuka Pharmaceutical Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Otsuka Pharmaceutical Colorectal Cancer Drugs Products Introduction
5.2 Mylan
5.2.1 Mylan Company Profile
5.2.2 Mylan Business Overview
5.2.3 Mylan Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Mylan Colorectal Cancer Drugs Products Introduction
5.3 Merck Serono
5.3.1 Merck Serono Company Profile
5.3.2 Merck Serono Business Overview
5.3.3 Merck Serono Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Merck Serono Colorectal Cancer Drugs Products Introduction
5.4 Precision Biologics
5.4.1 Precision Biologics Company Profile
5.4.2 Precision Biologics Business Overview
5.4.3 Precision Biologics Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Precision Biologics Colorectal Cancer Drugs Products Introduction
5.5 Biothera
5.5.1 Biothera Company Profile
5.5.2 Biothera Business Overview
5.5.3 Biothera Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Biothera Colorectal Cancer Drugs Products Introduction
5.6 Eli Lilly
5.6.1 Eli Lilly Company Profile
5.6.2 Eli Lilly Business Overview
5.6.3 Eli Lilly Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Eli Lilly Colorectal Cancer Drugs Products Introduction
5.7 Nektar Therapeutics
5.7.1 Nektar Therapeutics Company Profile
5.7.2 Nektar Therapeutics Business Overview
5.7.3 Nektar Therapeutics Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Nektar Therapeutics Colorectal Cancer Drugs Products Introduction
5.8 Symphogen
5.8.1 Symphogen Company Profile
5.8.2 Symphogen Business Overview
5.8.3 Symphogen Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Symphogen Colorectal Cancer Drugs Products Introduction
5.9 ThromboGenics
5.9.1 ThromboGenics Company Profile
5.9.2 ThromboGenics Business Overview
5.9.3 ThromboGenics Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 ThromboGenics Colorectal Cancer Drugs Products Introduction
5.10 Taiho
5.10.1 Taiho Company Profile
5.10.2 Taiho Business Overview
5.10.3 Taiho Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Taiho Colorectal Cancer Drugs Products Introduction
5.11 Yakult Honsha
5.11.1 Yakult Honsha Company Profile
5.11.2 Yakult Honsha Business Overview
5.11.3 Yakult Honsha Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Yakult Honsha Colorectal Cancer Drugs Products Introduction
5.12 F. Hoffmann-La Roche
5.12.1 F. Hoffmann-La Roche Company Profile
5.12.2 F. Hoffmann-La Roche Business Overview
5.12.3 F. Hoffmann-La Roche Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 F. Hoffmann-La Roche Colorectal Cancer Drugs Products Introduction
5.13 Eisai
5.13.1 Eisai Company Profile
5.13.2 Eisai Business Overview
5.13.3 Eisai Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Eisai Colorectal Cancer Drugs Products Introduction
5.14 Amgen
5.14.1 Amgen Company Profile
5.14.2 Amgen Business Overview
5.14.3 Amgen Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Amgen Colorectal Cancer Drugs Products Introduction
5.15 Advenchen Laboratories
5.15.1 Advenchen Laboratories Company Profile
5.15.2 Advenchen Laboratories Business Overview
5.15.3 Advenchen Laboratories Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Advenchen Laboratories Colorectal Cancer Drugs Products Introduction
5.16 Daiichi Sankyo
5.16.1 Daiichi Sankyo Company Profile
5.16.2 Daiichi Sankyo Business Overview
5.16.3 Daiichi Sankyo Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 Daiichi Sankyo Colorectal Cancer Drugs Products Introduction
5.17 Bristol-Myers Squibb
5.17.1 Bristol-Myers Squibb Company Profile
5.17.2 Bristol-Myers Squibb Business Overview
5.17.3 Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 Bristol-Myers Squibb Colorectal Cancer Drugs Products Introduction
5.18 Debiopharm
5.18.1 Debiopharm Company Profile
5.18.2 Debiopharm Business Overview
5.18.3 Debiopharm Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.18.4 Debiopharm Colorectal Cancer Drugs Products Introduction
5.19 Takeda
5.19.1 Takeda Company Profile
5.19.2 Takeda Business Overview
5.19.3 Takeda Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.19.4 Takeda Colorectal Cancer Drugs Products Introduction
5.20 Aeterna Zentaris
5.20.1 Aeterna Zentaris Company Profile
5.20.2 Aeterna Zentaris Business Overview
5.20.3 Aeterna Zentaris Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.20.4 Aeterna Zentaris Colorectal Cancer Drugs Products Introduction
5.21 Oncothyreon
5.21.1 Oncothyreon Company Profile
5.21.2 Oncothyreon Business Overview
5.21.3 Oncothyreon Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.21.4 Oncothyreon Colorectal Cancer Drugs Products Introduction
5.22 Bavarian Nordic
5.22.1 Bavarian Nordic Company Profile
5.22.2 Bavarian Nordic Business Overview
5.22.3 Bavarian Nordic Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.22.4 Bavarian Nordic Colorectal Cancer Drugs Products Introduction
5.23 Xbiotech
5.23.1 Xbiotech Company Profile
5.23.2 Xbiotech Business Overview
5.23.3 Xbiotech Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.23.4 Xbiotech Colorectal Cancer Drugs Products Introduction
5.24 Teva
5.24.1 Teva Company Profile
5.24.2 Teva Business Overview
5.24.3 Teva Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.24.4 Teva Colorectal Cancer Drugs Products Introduction
5.25 Accord Healthcare
5.25.1 Accord Healthcare Company Profile
5.25.2 Accord Healthcare Business Overview
5.25.3 Accord Healthcare Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.25.4 Accord Healthcare Colorectal Cancer Drugs Products Introduction
5.26 Mologen
5.26.1 Mologen Company Profile
5.26.2 Mologen Business Overview
5.26.3 Mologen Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.26.4 Mologen Colorectal Cancer Drugs Products Introduction
5.27 Immodulon Therapeutics
5.27.1 Immodulon Therapeutics Company Profile
5.27.2 Immodulon Therapeutics Business Overview
5.27.3 Immodulon Therapeutics Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.27.4 Immodulon Therapeutics Colorectal Cancer Drugs Products Introduction
5.28 Sun Pharmaceutical
5.28.1 Sun Pharmaceutical Company Profile
5.28.2 Sun Pharmaceutical Business Overview
5.28.3 Sun Pharmaceutical Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.28.4 Sun Pharmaceutical Colorectal Cancer Drugs Products Introduction
5.29 Boehringer Ingelheim
5.29.1 Boehringer Ingelheim Company Profile
5.29.2 Boehringer Ingelheim Business Overview
5.29.3 Boehringer Ingelheim Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.29.4 Boehringer Ingelheim Colorectal Cancer Drugs Products Introduction
5.30 AstraZeneca
5.30.1 AstraZeneca Company Profile
5.30.2 AstraZeneca Business Overview
5.30.3 AstraZeneca Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.30.4 AstraZeneca Colorectal Cancer Drugs Products Introduction
5.31 Bayer
5.31.1 Bayer Company Profile
5.31.2 Bayer Business Overview
5.31.3 Bayer Colorectal Cancer Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.31.4 Bayer Colorectal Cancer Drugs Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Colorectal Cancer Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Colorectal Cancer Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Colorectal Cancer Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Colorectal Cancer Drugs Price by Types (2015-2020)
6.2 Global Colorectal Cancer Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Colorectal Cancer Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Colorectal Cancer Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Colorectal Cancer Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Colorectal Cancer Drugs Sales, Price and Growth Rate of Adenocarcinoma
6.3.2 Global Colorectal Cancer Drugs Sales, Price and Growth Rate of Gastrointestinal Stromal Tumors (GIST)
6.3.3 Global Colorectal Cancer Drugs Sales, Price and Growth Rate of Lymphoma
6.3.4 Global Colorectal Cancer Drugs Sales, Price and Growth Rate of Carcinoids
6.3.5 Global Colorectal Cancer Drugs Sales, Price and Growth Rate of Turcot Syndrome
6.3.6 Global Colorectal Cancer Drugs Sales, Price and Growth Rate of Peutz-Jeghers Syndrome (PJS)
6.3.7 Global Colorectal Cancer Drugs Sales, Price and Growth Rate of Familial Colorectal Cancer (FCC)
6.3.8 Global Colorectal Cancer Drugs Sales, Price and Growth Rate of Juvenile Polyposis Coli
6.4 Global Colorectal Cancer Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Adenocarcinoma Market Revenue and Sales Forecast (2020-2025)
Summary: Get latest Market Research Reports on Colorectal Cancer Drugs. Industry analysis & Market Report on Colorectal Cancer Drugs is a syndicated market report, published as Global Colorectal Cancer Drugs Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Colorectal Cancer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.